封面
市場調查報告書
商品編碼
1736741

全球不孕症檢測設備市場規模(按產品類型、應用、最終用戶、區域範圍和預測)

Global Fertility Testing Devices Market Size By Product Type, By Application, By End-User, By Geographic Scope And Forecast

出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

不孕不育檢測設備市場規模及預測

2024 年不孕症檢測設備市場規模為 5.1669 億美元,預計到 2032 年將達到 8.7984 億美元,預測期內(2026-2032 年)的複合年成長率為 6.88%。

推動全球不孕症檢測設備市場的因素

不孕症檢測設備市場的市場促進因素可能受到多種因素的影響,其中包括:

不孕症率上升:主要促進因素是全球不孕症病例的增加。導致不孕症上升的因素包括生育延遲、生活方式改變、環境因素以及潛在的健康問題,這些因素都增加了對不孕症檢測設備的需求。

接受度和認知度不斷提升:大眾對不孕症和生殖健康問題的認知日益加深。隨著不孕症檢測和治療方案被廣泛接受,越來越多的個人和夫妻積極尋求診斷答案,從而推動市場擴張。

技術發展:隨著技術進步,不孕症檢測的準確性和可近性不斷提高,包括更易於使用、更準確且非侵入性的檢測設備的開發。消費者越來越傾向於智慧型手機應用程式、家用檢測套組和電子排卵監測器等創新產品。

延後生育趨勢:隨著越來越多的人因個人、職業或經濟原因而推遲生育,不孕症監測和生殖健康也越來越受到重視。老年人和夫婦擴大使用不孕症檢測設備來確定他們的生殖狀況並制定懷孕計劃。

其他疾病和卵巢卵巢症候群 (PCOS) 發病率上升:PCOS 和其他影響生育能力的荷爾蒙疾病的流行推動了生育測試設備需求的不斷成長。這些疾病需要及早診斷和治療,以改善生育結果。

家用檢測套組的普及:由於家用不孕不育檢測套組的實用性和普及性,市場規模顯著成長。這些套件越來越受歡迎,因為它們讓人們能夠輕鬆、謹慎地檢查自己的生殖狀況。

政府措施和鼓勵性醫療保健項目:各國政府和醫療保健機構越來越重視生殖健康,透過提供資金、補貼和支持項目,為不孕症治療和診斷提供資金支持。這些項目有助於擴大不孕症檢測設備的普及。

生育診所和專家數量的成長:生育診所和專家數量的成長推動了全球不孕症檢測設備市場的發展。這些診所使用尖端診斷技術頻繁地進行不孕症檢查,這推動了對此類設備的需求。

醫療支出和可支配收入的增加:尤其是在新興經濟體,可支配收入的增加和醫療成本的上升,使得越來越多的人能夠負擔得起不孕症檢測和治療費用。這種經濟擴張正在推動不孕症檢測設備市場的發展。

個人化醫療和醫學研究的發展:個人化醫療領域正在不斷擴展,其進步有助於創造更先進、更個人化的不孕症檢測方案。這些發展提高了不孕症評估的準確性和有效性。

限制全球不孕症檢測設備市場的因素

不孕症檢測設備市場面臨諸多限制與挑戰,包括:

昂貴的設備:不孕症檢測設備價格不菲,尤其是最尖端科技的型號。高昂的費用可能會限制設備的可及性,尤其是對於沒有全額醫療保險或可支配收入較低的地區的人來說。

知識與教育匱乏:大眾通常對不孕症相關問題缺乏了解,包括不孕症檢測設備的普及程度。這種無知可能導致不孕症檢測設備的使用不足。

社會與文化污名:在許多國家,談論不孕症仍然令人反感。社會對不孕症的污名化可能會阻礙人們接受檢測和治療,從而限制市場擴張。

準確性和可靠性的差異:不孕症檢測設備的準確性和可靠性可能存在差異。不孕症檢測設備的準確性和可靠性可能存在差異,這可能會導致消費者信心下降,並阻礙不孕症檢測設備的廣泛使用。高準確性和可靠性對於市場繁榮發展至關重要。

監管挑戰:生育測試設備受到嚴格監管。獲得監管部門的批准可能成本高昂且耗時,從而限制了產品的市場准入並延遲了新產品的上市。

缺乏標準化:如果沒有既定的測試程序和性能標準,設備性能可能會出現差異。缺乏標準化會造成混亂,並降低客戶信心。

保險覆蓋和報銷問題:保險報銷政策差異很大,不孕症相關的檢查和治療並非總是在保險範圍內。保險覆蓋不足可能會限制不孕症檢測設備的使用。

經濟因素:消費者在非必需醫療保健產品(例如生育測試設備)上的支出可能會受到經濟衰退和經濟限制的影響。經濟不確定性可能導致消費需求下降。

隱私問題:生育能力測試涉及敏感的個人訊息,對資料安全和隱私的擔憂可能會阻止人們使用這些設備,尤其是數位和連網的生育監測器。

技術限制:雖然技術發展推動市場向前發展,但在靈敏度、易用性以及設備與其他健康監測系統的整合方面仍存在限制。為了推動市場成長,必須克服這些技術障礙。

目錄

第1章全球不孕症檢測設備市場介紹

  • 市場概覽
  • 研究範圍
  • 先決條件

第2章執行摘要

第3章:已驗證的市場研究調查方法

  • 資料探勘
  • 驗證
  • 第一手資料
  • 資料來源列表

第4章全球不孕症檢測設備市場展望

  • 概述
  • 市場動態
    • 驅動程式
    • 限制因素
    • 機會
  • 波特五力模型
  • 價值鏈分析

第5章全球不孕症檢測設備市場(按產品)

  • 基礎體溫(BBT)體溫計
  • 排卵預測試劑套件(OPK)
  • 生育監測器
  • 男性不孕檢測產品
  • 子宮頸黏液監測儀
  • 荷爾蒙測試
  • 其他

第6章全球不孕症檢測設備市場(按應用)

  • 概述
  • 女性不孕不孕檢測
  • 男性不孕症檢測

第7章 全球生育測試設備市場(依最終用戶)

  • 概述
  • 居家醫療
  • 醫院
  • 不孕不育診所
  • 診斷中心

第8章全球不孕症檢測設備市場(按地區)

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 其他
    • 拉丁美洲
    • 中東和非洲

第9章全球不孕症偵測設備市場的競爭格局

  • 概述
  • 各公司市場排名
  • 重點發展策略

第10章 公司簡介

  • HiLin Life Products Inc.
  • Prestige Brands Holdings Inc.
  • Quidel Corporation
  • Swiss Precision Diagnostics GmbH
  • Advacare Pharma.
  • Babystart.
  • Church & Dwight Co. Inc.
  • Proov Predict and Confirm.
  • Fertility Focus Limited.
  • Modern Fertility Ovulation.

第11章 公司簡介 附錄

  • 相關調查
簡介目錄
Product Code: 40538

Fertility Testing Devices Market Size And Forecast

Fertility Testing Devices Market size was valued at USD 516.69 Million in 2024 and is projected to reach USD 879.84 Million by 2032, growing at a CAGR of 6.88% during the forecast period 2026-2032.

Global Fertility Testing Devices Market Drivers

The market drivers for the Fertility Testing Devices Market can be influenced by various factors. These may include:

Growing Infertility Rates: A major contributing factor is the growing incidence of infertility globally. The need for fertility testing equipment is increased by variables that lead to rising infertility rates, including delayed childbirth, changes in lifestyle, environmental factors, and underlying health issues.

Growing Acceptance and Awareness: The general public is becoming more conscious of concerns related to fertility and reproductive health. As fertility testing and treatment choices become more widely accepted, more people and couples are motivated to look for diagnostic answers, which propels market expansion.

Technological Developments: The accuracy and ease of fertility testing are continually improved by developments in technology, such as the creation of more user-friendly, accurate, and non-invasive testing instruments. Consumers are drawn to innovations like smartphone applications, home testing kits, and digital ovulation monitors.

Trends in Delayed Parenthood: As more people put off having children for personal, professional, or financial reasons, there is a greater emphasis on fertility monitoring and reproductive health. Fertility testing devices are more commonly used by older persons and couples to determine their reproductive status and schedule pregnancies.

Rise in Other Disorders and Polycystic Ovary Syndrome (PCOS): The increased need for fertility testing equipment is driven by the prevalence of PCOS and other hormone disorders that impact fertility. To improve the outcomes of reproduction, these diseases must be diagnosed and treated early.

Accessibility of Home Testing Kits: The market has grown considerably as a result of the practicality and accessibility of home fertility testing kits. These kits are becoming more and more popular because they make it easy and confidential for people to check their reproductive status.

Encouraging Government Initiatives and Healthcare Policies: With funding, subsidies, and supporting policies for fertility treatments and diagnostics, governments and healthcare organisations are putting more and more emphasis on reproductive health. These programmes aid in expanding the availability of fertility testing equipment.

Growing Number of Fertility Clinics and Specialists: The global fertility testing device market is being driven by the increasing number of fertility clinics and specialists. The need for such gadgets is driven by the fact that these clinics frequently check fertility using cutting-edge diagnostic technologies.

Increasing Spending on Healthcare and Disposable Income: More people are able to afford fertility tests and treatments thanks to rising disposable incomes and rising healthcare costs, especially in emerging nations. This expansion of the economy helps the market for fertility testing equipment.

Developments in Personalised Medicine and Medical Research: The field of personalised medicine is expanding, and its advancements help to create more advanced and individualised fertility testing options. These developments improve the precision and effectiveness of fertility evaluations.

Global Fertility Testing Devices Market Restraints

Several factors can act as restraints or challenges for the Fertility Testing Devices Market. These may include:

Expensive Devices: Fertility testing equipment can be costly, particularly when it comes to models that use cutting-edge technologies. Exorbitant expenses may restrict accessibility, especially for those without full health insurance or in areas with less discretionary income.

Limited Knowledge and Education: The general public frequently has little knowledge and comprehension of fertility-related issues, including the availability of fertility testing equipment. Underuse of these devices may result from this ignorance.

Social and Cultural Stigma: Talking about fertility problems is still frowned upon in many countries. The stigma attached to infertility in society can deter people from getting tested and treated, which would restrict market expansion.

Variability in Accuracy and Reliability: Fertility testing equipment's accuracy and dependability might change. The adoption of these gadgets can be hampered by inconsistent outcomes, which can erode consumer confidence. For the market to flourish, great precision and dependability are essential.

Regulatory Difficulties: Strict regulations apply to fertility testing equipment. Getting regulatory approval can be an expensive and time-consuming procedure that can limit market entry and postpone the release of new products.

Lack of Standardisation: Device performance may vary if there are no established testing procedures or performance standards. Confusion and a decline in customer confidence may result from this lack of standardisation.

Problems with Insurance Coverage and Reimbursement: Policies regarding insurance reimbursement might differ greatly, and tests and treatments related to fertility are not always covered by them. Insufficient insurance coverage may limit the availability of fertility testing equipment.

Economic Factors: Consumer expenditure on non-essential healthcare products, such as fertility testing equipment, can be impacted by economic downturns and financial restraints. Instability in the economy might lower consumer demand.

Privacy Concerns: Sensitive personal health data is involved in fertility testing. People may be discouraged from utilising these devices due to worries about data security and privacy, especially when it comes to digital or connected fertility monitors.

Technological Restrictions: Although technological developments are propelling the market forward, restrictions still exist with regard to the sensitivity, usability, and integration of devices with other health monitoring systems. For the market to grow, these technological obstacles must be overcome.

Global Fertility Testing Devices Market Segmentation Analysis

The Global Fertility Testing Devices Market is Segmented on the basis of Product Type, Application, End-User, and Geography.

Fertility Testing Devices Market, By Product Type

  • Ovulation Prediction Kits (OPKs): Devices that detect the surge in luteinizing hormone (LH) to predict ovulation.
  • Fertility Monitors: Advanced devices that track multiple fertility indicators such as basal body temperature (BBT), hormone levels, and cycle length.
  • Male Fertility Testing Kits: Devices used to test sperm count, motility, and overall semen quality.
  • Basal Body Temperature (BBT) Thermometers: Devices used to measure body temperature changes that indicate ovulation.
  • Cervical Mucus Monitors: Devices that assess the consistency of cervical mucus to predict fertility.
  • Hormone-based Tests: Tests that measure hormone levels such as follicle-stimulating hormone (FSH) and estrogen to assess fertility.
  • Others: Including digital fertility trackers, wearable devices, and mobile app-based fertility trackers.

Fertility Testing Devices Market, By Application

  • Female Fertility Testing: Devices specifically designed to assess and monitor fertility in women.
  • Male Fertility Testing: Devices designed to evaluate sperm quality and overall male fertility.

Fertility Testing Devices Market, By End-User

  • Home Care Settings: Individuals and couples using fertility testing devices at home.
  • Hospitals: Medical facilities where fertility testing devices are used as part of fertility assessments and treatments.
  • Fertility Clinics: Specialized clinics focused on diagnosing and treating fertility issues.
  • Diagnostic Centers: Centers that provide comprehensive diagnostic services including fertility testing.

Fertility Testing Devices Market, By Geography

  • North America: Includes the United States and Canada, characterized by high awareness and adoption of fertility testing devices.
  • Europe: Includes countries such as Germany, the UK, France, Italy, and Spain, with strong healthcare systems and a growing focus on fertility health.
  • Asia-Pacific: Includes China, Japan, India, South Korea, and Australia, where increasing healthcare investments and awareness are driving market growth.
  • Latin America: Includes Brazil, Mexico, and other countries in Central and South America, with emerging healthcare markets.
  • Middle East and Africa: Includes countries such as Saudi Arabia, UAE, South Africa, and others, where healthcare infrastructure is expanding and awareness of fertility issues is rising.

Key Players

  • The major players in the Fertility Testing Devices Market are:
  • Church & Dwight Co. Inc.
  • SPD Swiss Precision Diagnostics GmbH
  • AccuQuik
  • Prestige Brands Holdings.Inc.
  • HiLin Life Products.Inc.
  • Fertility Focus Limited
  • Geratherm Medical AG
  • Babystart Ltd
  • Quidel Corporation
  • UEBE Medical GmbH
  • Biozhena Corporation
  • Alere Inc.
  • Taidoc Technology Corporation
  • Fairhaven Health LLC

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL FERTILITY TESTING DEVICES MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL FERTILITY TESTING DEVICES MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL FERTILITY TESTING DEVICES MARKET, BY PRODUCT

  • 5.1 Basal Body Temperature (BBT) Thermometers
  • 5.2 Ovulation Prediction Kits (OPKs)
  • 5.3 Fertility Monitors
  • 5.4 Male Fertility Testing Products
  • 5.5 Cervical Mucus Monitors:
  • 5.6 Hormone-based Tests
  • 5.7 Others:

6 GLOBAL FERTILITY TESTING DEVICES MARKET, BY APPLICATION

  • 6.1 Overview
  • 6.2 Female Fertility Testing
  • 6.3 Male Fertility Testing

7 GLOBAL FERTILITY TESTING DEVICES MARKET, BY END-USER

  • 7.1 Overview
  • 7.2 Home Care Settings
  • 7.3 Hospitals
  • 7.4 Fertility Clinics
  • 7.5 Diagnostic Centers

8 GLOBAL FERTILITY TESTING DEVICES MARKET, BY GEOGRAPHY

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 U.K.
    • 8.3.3 France
    • 8.3.4 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Rest of Asia Pacific
  • 8.5 Rest of the World
    • 8.5.1 Latin America
    • 8.5.2 Middle East and Africa

9 GLOBAL FERTILITY TESTING DEVICES MARKET COMPETITIVE LANDSCAPE

  • 9.1 Overview
  • 9.2 Company Market Ranking
  • 9.3 Key Development Strategies

10 COMPANY PROFILES

  • 10.1 HiLin Life Products Inc.
    • 10.1.1 Overview
    • 10.1.2 Financial Performance
    • 10.1.3 Product Outlook
    • 10.1.4 Key Developments
  • 10.2 Prestige Brands Holdings Inc.
    • 10.2.1 Overview
    • 10.2.2 Financial Performance
    • 10.2.3 Product Outlook
    • 10.2.4 Key Developments
  • 10.3 Quidel Corporation.
    • 10.3.1 Overview
    • 10.3.2 Financial Performance
    • 10.3.3 Product Outlook
    • 10.3.4 Key Developments
  • 10.4 Swiss Precision Diagnostics GmbH.
    • 10.4.1 Overview
    • 10.4.2 Financial Performance
    • 10.4.3 Product Outlook
    • 10.4.4 Key Developments
  • 10.5 Advacare Pharma.
    • 10.5.1 Overview
    • 10.5.2 Financial Performance
    • 10.5.3 Product Outlook
    • 10.5.4 Key Developments
  • 10.6 Babystart.
    • 10.6.1 Overview
    • 10.6.2 Financial Performance
    • 10.6.3 Product Outlook
    • 10.6.4 Key Development
  • 10.7 Church & Dwight Co. Inc.
    • 10.7.1 Overview
    • 10.7.2 Financial Performance
    • 10.7.3 Product Outlook
    • 10.7.4 Key Developments
  • 10.8 Proov Predict and Confirm.
    • 10.8.1 Overview
    • 10.8.2 Financial Performance
    • 10.8.3 Product Outlook
    • 10.8.4 Key Developments
  • 10.9 Fertility Focus Limited.
    • 10.9.1 Overview
    • 10.9.2 Financial Performance
    • 10.9.3 Product Outlook
    • 10.9.4 Key Development
  • 10.10 Modern Fertility Ovulation.
    • 10.10.1 Overview
    • 10.10.2 Financial Performance
    • 10.10.3 Product Outlook
    • 10.10.4 Key Development

11 APPENDIX

  • 11.1 Related Research